Re is an innovative experimental medication currently being developed for the treatment of obesity and potentially type 2 diabetes. It belongs to a new class of drugs known as triple agonists, which sets it apart from existing treatments. R works by simultaneously activating three different receptors involved in metabolism and appetite regulation: the glucagon-like peptide-1 receptor, the glucose-dependent insulinotropic polypeptide receptor, and the glucagon receptor. R is a groundbreaking medication designed to help people by targeting three key hormone receptors: GIP and glucagon. These receptors play an essential role in controlling appetite, metabolism, and fat storage. By addressing all three pathways, r offers a more comprehensive approach to compared to other treatments that only target one hormone.
Looks like there are no reviews for this Product
Looks like there are no reviews for this product
China
We are a manufacturer and exporter of dermal fillers and a wide range of beauty and aesthetic products. As a dermal filler producer, we ensure high-quality standards, safety, and consistency across all our products for international markets.
China
A virtual marketplace leading your business into the future
